Fischer Medical Ventures Limited (NSE:FISCHER)

Fischer Medical Ventures Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	26,583	57,275	33,419	14	13	4
Market Cap Growth	-29.99%	71.39%	231203.81%	7.62%	206.08%	-48.64%
Enterprise Value	26,530	57,247	33,399	19	16	5
PE Ratio	67.38	4741.67	1818.31	-	-	3.12
PS Ratio	10.22	51.74	159.28	8.05	-	2.66
PB Ratio	7.37	16.95	41.20	-5.43	-5.85	141.48
P/TBV Ratio	7.50	17.24	42.36	-	-	141.48
EV/Sales Ratio	10.20	51.71	159.18	10.53	-	3.29
EV/EBITDA Ratio	61.75	2416.61	1888.98	-	-	-
EV/EBIT Ratio	63.57	3346.01	1990.88	123.50	-	-
Debt / Equity Ratio	0.10	0.25	0.02	-2.15	-1.70	75.10
Debt / EBITDA Ratio	0.86	33.94	0.90	-	-	-
Net Debt / Equity Ratio	-0.02	-0.49	-0.45	-2.01	-1.63	60.61
Net Debt / EBITDA Ratio	-0.14	-70.07	-20.51	-	-	-
Net Debt / FCF Ratio	-	1.79	4.63	-3.67	-2.11	-3.28
Asset Turnover	-	0.41	0.48	0.66	-	0.84
Inventory Turnover	-	13.46	-	-	-	-
Quick Ratio	-	3.24	15.97	4.32	0.04	2.54
Current Ratio	-	3.59	18.37	5.19	0.12	4.37
Return on Equity (ROE)	-	0.58%	4.55%	-	-	-
Return on Assets (ROA)	-	0.39%	2.42%	3.52%	-53.14%	-5.62%
Return on Invested Capital (ROIC)	9.27%	0.86%	6.47%	7.39%	-112.62%	-21.19%
Return on Capital Employed (ROCE)	-	0.50%	2.00%	5.00%	82.20%	-7.50%
Earnings Yield	1.48%	0.02%	0.06%	-2.53%	-17.33%	32.06%
FCF Yield	-	-1.62%	-0.24%	-10.10%	-13.18%	-13.06%
Buyback Yield / Dilution	-60.37%	-295.30%	-9752.91%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.